Using malaria as a model disease,,ve engineered the surface of tobacco
mosaic tobamovirus (TMV) for presentation of selected epitopes to the
mammalian immune system. The TMV coat protein is a well-characterized
and abundant self-assembling polymer previously shown to be a highly
immunogenic carrier. Selected B-cell epitopes were either inserted int
o the surface loop region of the TMV coat protein or fused to the C te
rminus using the leaky stop signal derived from the replicase protein
reading frame. Tobacco plants systemically infected with each of these
constructs contained high titers of genetically stable recombinant vi
rus, enabling purification of the chimeric particles ire high yield. S
ymptoms induced in tobacco ranged from a normal mosaic pattern similar
to that induced by the parental U1 strain to a unique bright yellow m
osaic. As measured by quantitative ELISA against synthetic peptide sta
ndards, wild type TMV coat protein and fusion protein synthesized by t
he leaky stop mechanism coassembled into virus particles at the predic
ted ratio of similar to 20:1. Recombinant plant viruses have the poten
tial to meet the need for scalable and cost effective production of su
bunit vaccines that can be easily stored and administered.